Metastatic Lung Tumors
Metastatic Lung Tumors - Related Videos
03:52
Experimental Metastatic Melanoma Mouse Model: A Platform to Study the Metastatic Potential of Melanoma Cells in the Lungs
0 Views •
2023
In this video, melanoma cells are intravenously injected through the tail vein in the mouse model. The melanoma cells further travel through the circulatory system, adapting to the distant microenvironment and causing metastasis in organs like lungs.
07:31
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
0 Views •
Cited by 13 •
2016
Metastasis plays a profound role in the virulence of cancer, accounting for an estimated 90% of deaths. We report a protocol for a metastatic melanoma model in mice that is useful for determining the efficacy of therapeutic agents against this clinical phenomenon.
09:14
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
0 Views •
Cited by 39 •
2011
A modified 3-D in vitro system is presented in which growth characteristics of several tumor cell lines in reconstituted basement membrane correlate with the dormant or proliferative behavior of the tumor cells at a metastatic secondary site in vivo.
06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
0 Views •
Cited by 13 •
2015
The goal of this protocol is to study breast tumorigenesis. With this technique, mouse mammary tumors are removed and primary cells are prepared from tumors. A lung extraction protocol is included for studying lung metastasis. Furthermore, another protocol for analyzing mouse embryonic fibroblasts from the mouse embryo is included.
04:28
Lung Tumor Cell Recruitment Assay
0 Views •
2019
This manuscript describes a method to quantify tumor cell accumulation in the lungs in an animal model of tumor metastasis.
FAQs
The metastatic sequence includes invasion of nearby tissue, entry into blood or lymphatic vessels, survival during circulation, and exit into pulmonary tissue. Successful establishment depends on more than physical arrival: interactions with the local lung microenvironment can support colonization and subsequent tumor growth. Studying each step helps researchers identify where dissemination might be interrupted.
Pulmonary tissue can provide local conditions and cellular interactions that help disseminated malignant cells survive, colonize, and grow. This means metastatic progression is influenced not only by the properties of the traveling tumor cells but also by the tissue they enter. Cancer research therefore examines the microenvironment as a potential source of mechanisms that sustain metastatic disease.
Their distinction depends on determining whether the malignant cells originated in the lung or arrived from another primary site. Imaging, biopsy, and molecular profiling provide complementary evidence for this assessment. Accurate classification matters because the diagnosis affects cancer staging, prognosis, and treatment decisions, while also helping researchers compare dissemination biology with processes arising in the lung itself.
Evaluation combines imaging with biopsy and molecular profiling rather than relying on a single source of information. Imaging helps characterize disease in the lungs, biopsy provides tumor tissue for direct examination, and molecular profiling supplies additional evidence about tumor identity. Together, these approaches help distinguish metastatic disease from primary lung cancers and support more informed clinical interpretation.
Recognizing that lung lesions represent metastatic disease provides important information for cancer staging and prognosis. It also helps guide systemic therapy selection by placing the pulmonary findings in the context of the original cancer. This distinction can change how researchers and clinicians interpret disease extent, expected outcomes, and the rationale for investigating treatments aimed at disseminated cancer.
Cancer researchers investigate how malignant cells disseminate, survive circulation, exit into pulmonary tissue, and receive support from the local microenvironment. They also study methods for distinguishing metastases from primary lung cancers through imaging, biopsy, and molecular profiling. These efforts can reveal mechanisms that prevent dissemination or identify vulnerabilities for targeting established metastatic disease.